Taisho remains a leading consumer health producer, but it continues to rely almost exclusively on the Japanese market. Recent moves to diversify outside of Japan include the 2009 acquisition of some Bristol-Myers Squibb analgesics brands in Asia Pacific, as well as the 2011 acquisition of Hoe Pharmaceuticals based in Malaysia. Although these acquisitions represent a move in the right direct, further action is needed to diversify its geographic reach.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Euromonitor International's report on Taisho Pharmaceutical Co Ltd delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.
Company and market share data provide a detailed look at the financial position of Taisho Pharmaceutical Co Ltd, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Taisho Pharmaceutical Co Ltd.
Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.
Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
Reports are delivered in PDF format and can be downloaded from your online account immediately after purchase.